Web Desc
COVID-19: One Year Later - VIRTUAL CONTENT AVAILABLE ON DEMAND
Organizer(s): Katherine Kedzierska, Carolina B. López, Kanta Subbarao, JoAnn A. Suzich, Paul G. Thomas
Date: February 08 - 09, 2021
Location: Virtual at your computer. Recorded presentation content is available On Demand.
Sponsored by AbbVie Inc., AstraZeneca, BioLegend, Inc., Gilead Sciences, Inc., Merck & Co., Inc. and Nektar Therapeutics
For important information on the coronavirus, please click here
Summary of Meeting:
Over the course of 2020, the novel coronavirus SARS-CoV-2 has spread across the globe causing an ongoing pandemic responsible for the deaths of more than 1.3 million people. It has brought countries to a standstill, strained hospital systems, and plunged the world into an economic recession. Against this backdrop, the mini Keystone eSymposium “COVID-19: One Year Later” will begin with a keynote address by Dr. Anthony Fauci and then delve into the biology of SARS-CoV-2 transmissibility and spread. Human innate and adaptive immune responses to SARS-CoV-2 will be discussed and updates on the current state of monoclonal antibody-based therapies and prophylactic vaccines will be presented. As people around the globe await the arrival of effective preventive and treatment strategies that might bring an end to the current crisis, this mini-symposium will discuss the risk of future zoonotic transmissions of coronaviruses, especially from bats. Finally, the successes and challenges of modelling COVID-19 dynamics will be the focus of a panel discussion with emphasis on lessons learned for future pandemics. This mini-symposium will be of broad interest to scientists across many disciplines who wish to gain a better understanding of the current pandemic and the application of this knowledge to the prevention of future outbreaks.
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
AbbVie Inc.AstraZenecaBioLegend, Inc.Gilead Sciences, Inc.Merck & Co., Inc.Nektar Therapeutics
We gratefully acknowledge additional support for this conference from:
AdipoGen Life SciencesNanoString Technologies, Inc.


Avanti Polar Lipids, Inc.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Monday, February 08 | 1:00PM - 1:50PM
Welcoming Remarks and Keynote Address(1pm Denver/Mountain Ti
me Start)

Speaker 1 of 2
* Kanta Subbarao, WHO Collaborating Centre for Reference and Research on Influenza, Australia

Monday, February 08 | 1:00PM - 1:50PM
Welcoming Remarks and Keynote Address(1pm Denver/Mountain Ti
me Start)

Speaker 2 of 2
Anthony S. Fauci, NIAID, National Institutes of Health, USA

Monday, February 08 | 1:50PM - 2:55PM
Update on Vaccine and Ab Trials (1:50pm Denver/Mountain Time
Start)


Speaker 1 of 4
* Kanta Subbarao, WHO Collaborating Centre for Reference and Research on Influenza, Australia

Monday, February 08 | 1:50PM - 2:55PM
Update on Vaccine and Ab Trials (1:50pm Denver/Mountain Time
Start)


Speaker 2 of 4
* Carolina B. López, Washington University School of Medicine, USA

Monday, February 08 | 1:50PM - 2:55PM
Update on Vaccine and Ab Trials (1:50pm Denver/Mountain Time
Start)


Speaker 3 of 4
Mark T. Esser, AstraZeneca, USA
From Lab to Jab. An Update on AstraZeneca’s Vaccine and Therapeutic Antibody Programs

Monday, February 08 | 1:50PM - 2:55PM
Update on Vaccine and Ab Trials (1:50pm Denver/Mountain Time
Start)


Speaker 4 of 4
Kathleen M. Neuzil, University of Maryland, USA
Vaccines against SARS-CoV-2: Current Status and Future Directions

Monday, February 08 | 3:10PM - 4:15PM
Current Understanding of the High Infectivity and Transmissi
bility of SARS-CoV-2 (3:10pm Denver/Mountain Time Start)


Speaker 1 of 4
* Kanta Subbarao, WHO Collaborating Centre for Reference and Research on Influenza, Australia

Monday, February 08 | 3:10PM - 4:15PM
Current Understanding of the High Infectivity and Transmissi
bility of SARS-CoV-2 (3:10pm Denver/Mountain Time Start)


Speaker 2 of 4
* Carolina B. López, Washington University School of Medicine, USA

Monday, February 08 | 3:10PM - 4:15PM
Current Understanding of the High Infectivity and Transmissi
bility of SARS-CoV-2 (3:10pm Denver/Mountain Time Start)


Speaker 3 of 4
Linsey Marr, Virginia Tech, USA
A Paradigm Shift in Airborne Transmission?

Monday, February 08 | 3:10PM - 4:15PM
Current Understanding of the High Infectivity and Transmissi
bility of SARS-CoV-2 (3:10pm Denver/Mountain Time Start)


Speaker 4 of 4
Benjamin John Cowling, Hong Kong University, Hong Kong
Transmissibility of SARS-CoV-2 Compared to Other Coronaviruses

Monday, February 08 | 4:15PM - 4:45PM
The Risk of Another Zoonotic Coronavirus from Bats (4:15pm D
enver/Mountain Time Start)


Speaker 1 of 3
* Kanta Subbarao, WHO Collaborating Centre for Reference and Research on Influenza, Australia

Monday, February 08 | 4:15PM - 4:45PM
The Risk of Another Zoonotic Coronavirus from Bats (4:15pm D
enver/Mountain Time Start)


Speaker 2 of 3
* Carolina B. López, Washington University School of Medicine, USA

Monday, February 08 | 4:15PM - 4:45PM
The Risk of Another Zoonotic Coronavirus from Bats (4:15pm D
enver/Mountain Time Start)


Speaker 3 of 3
Ralph S. Baric, University of North Carolina at Chapel Hill, USA
The Risk of Another Zoonotic Coronavirus from Bats

Monday, February 08 | 4:45PM - 5:00PM
Closing Remarks (4:45pm Denver/Mountain Time Start)


Tuesday, February 09 | 10:00AM - 11:00AM
Networking Lounge (10am Denver/Mountain Time Start)


Tuesday, February 09 | 11:00AM - 12:00PM
Meet the Editors (11am Denver/Mountain Time Start)

Speaker 1 of 4
Gaia Trincucci, Journal of Experimental Medicine, USA

Tuesday, February 09 | 11:00AM - 12:00PM
Meet the Editors (11am Denver/Mountain Time Start)

Speaker 2 of 4
Achim Breiling, EMBO, Germany

Tuesday, February 09 | 11:00AM - 12:00PM
Meet the Editors (11am Denver/Mountain Time Start)

Speaker 3 of 4
Alessandra Fornarelli, Frontiers, Switzerland

Tuesday, February 09 | 11:00AM - 12:00PM
Meet the Editors (11am Denver/Mountain Time Start)

Speaker 4 of 4
Sara Hamilton, Cell Press, USA



Tuesday, February 09 | 1:00PM - 2:05PM
Immunology & Pathogenesis (1pm Denver/Mountain Time Start)

Speaker 1 of 4
* Katherine Kedzierska, University of Melbourne, Australia

Tuesday, February 09 | 1:00PM - 2:05PM
Immunology & Pathogenesis (1pm Denver/Mountain Time Start)

Speaker 2 of 4
* Paul G. Thomas, St. Jude Children's Research Hospital, USA

Tuesday, February 09 | 1:00PM - 2:05PM
Immunology & Pathogenesis (1pm Denver/Mountain Time Start)

Speaker 3 of 4
Catherine A. Blish, Stanford University School of Medicine, USA
Dysregulation of Innate Immunity and Hematopoiesis during COVID-19

Tuesday, February 09 | 1:00PM - 2:05PM
Immunology & Pathogenesis (1pm Denver/Mountain Time Start)

Speaker 4 of 4
Lisa F.P. Ng, SIgN (Singapore Immunology Network), Singapore
Infection and Immunity of SARS-CoV-2 Infections: Diagnostics and Therapies for COVID-19

Tuesday, February 09 | 2:05PM - 3:10PM
Adaptive Immunity. T and B Cell Responses: Kinetics, Cross R
eactivity, Relationship with Disease Severity, Memory I (2:05pm Denver/Mountain Time Start)


Speaker 1 of 4
* Katherine Kedzierska, University of Melbourne, Australia

Tuesday, February 09 | 2:05PM - 3:10PM
Adaptive Immunity. T and B Cell Responses: Kinetics, Cross R
eactivity, Relationship with Disease Severity, Memory I (2:05pm Denver/Mountain Time Start)


Speaker 2 of 4
* Paul G. Thomas, St. Jude Children's Research Hospital, USA

Tuesday, February 09 | 2:05PM - 3:10PM
Adaptive Immunity. T and B Cell Responses: Kinetics, Cross R
eactivity, Relationship with Disease Severity, Memory I (2:05pm Denver/Mountain Time Start)


Speaker 3 of 4
Ali H. Ellebedy, Washington University School of Medicine, USA
Human B Cell Responses to SARS-CoV-2

Tuesday, February 09 | 2:05PM - 3:10PM
Adaptive Immunity. T and B Cell Responses: Kinetics, Cross R
eactivity, Relationship with Disease Severity, Memory I (2:05pm Denver/Mountain Time Start)


Speaker 4 of 4
Marcus Buggert, Karolinska Institutet, Sweden
T Cell Responses

Tuesday, February 09 | 3:20PM - 4:00PM
Adaptive Immunity. T and B Cell Responses: Kinetics, Cross R
eactivity, Relationship with Disease Severity, Memory II (3:20pm Denver/Mountain Time Start)


Speaker 1 of 4
* Katherine Kedzierska, University of Melbourne, Australia

Tuesday, February 09 | 3:20PM - 4:00PM
Adaptive Immunity. T and B Cell Responses: Kinetics, Cross R
eactivity, Relationship with Disease Severity, Memory II (3:20pm Denver/Mountain Time Start)


Speaker 2 of 4
* Paul G. Thomas, St. Jude Children's Research Hospital, USA

Tuesday, February 09 | 3:20PM - 4:00PM
Adaptive Immunity. T and B Cell Responses: Kinetics, Cross R
eactivity, Relationship with Disease Severity, Memory II (3:20pm Denver/Mountain Time Start)


Speaker 3 of 4
Anastasia Minervina, St. Jude Children's Research Hospital/IBCh RAS, Moscow, Russia, USA
Longitudinal Tracking of T Cell Clones in COVID-19

Tuesday, February 09 | 3:20PM - 4:00PM
Adaptive Immunity. T and B Cell Responses: Kinetics, Cross R
eactivity, Relationship with Disease Severity, Memory II (3:20pm Denver/Mountain Time Start)


Speaker 4 of 4
Oanh Nguyen, University of Melbourne, Australia
Tfh, B Cells and Antibodies in COVID-19

Tuesday, February 09 | 4:00PM - 4:50PM
Panel Discussion: COVID-19 Modeling: What Worked Well, What
Didn’t and What Data do We Need/Want to Plan for Future Pandemics (4pm Denver/Mountain Time Start)

Speaker 1 of 5
* Lone Simonsen, Roskilde Universitet, Denmark

Tuesday, February 09 | 4:00PM - 4:50PM
Panel Discussion: COVID-19 Modeling: What Worked Well, What
Didn’t and What Data do We Need/Want to Plan for Future Pandemics (4pm Denver/Mountain Time Start)

Speaker 2 of 5
Jodie McVernon, Doherty Institute, Australia

Tuesday, February 09 | 4:00PM - 4:50PM
Panel Discussion: COVID-19 Modeling: What Worked Well, What
Didn’t and What Data do We Need/Want to Plan for Future Pandemics (4pm Denver/Mountain Time Start)

Speaker 3 of 5
Christopher J.L. Murray, University of Washington, USA

Tuesday, February 09 | 4:00PM - 4:50PM
Panel Discussion: COVID-19 Modeling: What Worked Well, What
Didn’t and What Data do We Need/Want to Plan for Future Pandemics (4pm Denver/Mountain Time Start)

Speaker 4 of 5
Gabriel M. Leung, University of Hong Kong, Hong Kong

Tuesday, February 09 | 4:00PM - 4:50PM
Panel Discussion: COVID-19 Modeling: What Worked Well, What
Didn’t and What Data do We Need/Want to Plan for Future Pandemics (4pm Denver/Mountain Time Start)

Speaker 5 of 5
Rosalind Eggo, London School of Hygiene & Tropical Medicine, UK

Tuesday, February 09 | 4:50PM - 5:00PM
Closing Remarks (4:45pm Denver/Mountain Time Start)


*Session Chair.